<DOC>
	<DOCNO>NCT02235064</DOCNO>
	<brief_summary>The purpose project ass effectiveness preventative antidepressant immediately follow delivery postpartum depression rate woman high risk due prior history depression postpartum depression .</brief_summary>
	<brief_title>Prophylactic Use Postpartum Sertraline Prevent Postpartum Depression</brief_title>
	<detailed_description>Eligible woman study would identify antepartum three obstetrical group deliver Cooper University Hospital : Cooper Faculty Group , Women 's Care Center , CamCare . Potentially eligible woman would refer study coordinator principal investigator discus nature study . Those woman agree trial would screen baseline structure psychiatric evaluation third trim pregnancy rule-out current depressive illness . If evidence depression antepartum evaluation , patient deliver liveborn singleton fetus 34 0/7 week great would re-evaluated prior discharge , score &lt; /= 12 Edinburgh Postpartum Depression scale , would enrol trial . Patients would assign either sertraline 50 mg daily identical appear placebo 12 week . Group allocation would determine restricted-randomization technique variable block length , sequence generate someone associate participant assignment . Assignment would keep sequentially numbered , opaque , sealed envelope ( SNOSE ) pharmacy , would dispense medication ( placebo ) . Patients would give 30 day supply day discharge , refill provide study coordinator ( pharmacy ) 12 week four-day supply 25 mg Sertraline placebo end 12 week taper . Patients would also undergo follow-up blind structure psychiatric evaluation 4 week , 8 week , 12 week assess adverse reaction assign treatment agent , administration questionnaires/evaluation ass development depression . Any patient recognize clinical depression would immediately remove active participation study refer Cooper Psychiatry department outside psychiatrist ongoing evaluation treatment . Medication receive ( Sertraline Placebo ) would necessarily reveal Psych purpose guide appropriate treatment . All woman randomize would analyze accord group assignment ( intent-to-treat ) . Demographic information , include patient age , race/ethnicity , gravidity , parity , gestational age delivery , infant birth weight , well infant weight standard Pediatric visit ( obtain verbally mother ) would record compare use Student t-test normally distribute continuous data , Mann-Whitney U non-normative continuous data , Chi Square test Fisher Exact test categorical data . A sample size calculation perform . Based anticipated rate postpartum depression ( PPD ) 30 % placebo group , would need 62 subject group detect reduction PPD 10 % sertraline group , power .8 Type I error .05 . Based 2200 delivery occur annually Cooper University Hospital , anticipate would take 2-3 year recruit 124 subject study .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression , Postpartum</mesh_term>
	<mesh_term>Sertraline</mesh_term>
	<criteria>1 . Past history depression postpartum depression 2 . Singleton gestation 3 . Delivery &gt; 34 week gestation 4 . No current clinical evidence depression 5 . Able read understand write English language 1 . Multiple gestation 2 . Delivery prior 34 week 3 . Delivery outside Cooper University Hospital 4 . Major fetal anomaly fetal demise 5 . Current use antidepressants 6 . Evidence active depression antepartum evaluation 7 . Edinburgh Postpartum Depression scale &gt; 12 prior discharge hospital 8 . Maternal age &lt; 18 year 9 . Infant Neonatal Intensive Care Unit ( NICU ) time patient discharge hospital 10 . Known suspected allergy Sertraline</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>